ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen (Q38945255)

7 September 2017

title

ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen (English)

1 reference

7 September 2017

8

Li Li

1 reference

7 September 2017

Ying-Hui Song

1

1 reference

7 September 2017

Mei-Zuo Zhong

2

1 reference

7 September 2017

Ping-Ping Gan

3

1 reference

7 September 2017

Ping-Yong Yi

4

1 reference

7 September 2017

You-Hong Tang

5

1 reference

7 September 2017

Yi-Ping Liu

6

1 reference

7 September 2017

Jin-Qiong Jiang

7

1 reference

7 September 2017

publication date

25 October 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

35

1 reference

7 September 2017

issue

12

1 reference

7 September 2017

page(s)

11809-11817

1 reference

14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Normal and neoplastic urothelial stem cells: getting to the root of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2335-9

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25344211

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25344211

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25344211

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2335-9

1 reference

Dimensions Publication ID

7 September 2017

1025899896

0 references

1 reference